Clinical trials
Completed Fibromyalgia trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
105 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 6 |
| 2007 | 4 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 5 |
| 2014 | 1 |
| 2015 | 7 |
| 2016 | 10 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 11 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 14 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 105 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Universidad de Granada | 15 |
| University of Valencia | 6 |
| Camilo Jose Cela University | 5 |
| Universidad de Almeria | 5 |
| Daiichi Sankyo | 3 |
| Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 3 |
| Universidad Rey Juan Carlos | 3 |
| Universitat Jaume I | 3 |
| University of Castilla-La Mancha | 3 |
| Cardenal Herrera University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fibromyalgia | 105 |
| Pain | 25 |
| Chronic Pain | 12 |
| Anxiety Disorders | 6 |
| Fatigue | 4 |
| Fatigue Syndrome, Chronic | 4 |
| Arthralgia | 2 |
| Myalgia | 2 |
| Myofascial Pain Syndromes | 2 |
| Temporomandibular Joint Dysfunction Syndrome | 2 |
Trials
Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.
5 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.